Unknown

Dataset Information

Hyperbaric oxygen therapy to prevent central airway stenosis after lung transplantation.


ABSTRACT:

Background

Central airway stenosis (CAS) is a severe airway complication after lung transplantation associated with bronchial ischemia and necrosis. We sought to determine whether hyperbaric oxygen therapy (HBOT), an established treatment for tissue ischemia, attenuates post-transplant bronchial injury.

Methods

We performed a randomized, controlled trial comparing usual care with HBOT (2 atm absolute for 2 hours × 20 sessions) in subjects with extensive airway necrosis 4 weeks after transplantation. Endobronchial biopsies were collected at 4, 7, and 10 weeks after transplantation for a quantitative polymerase chain reaction. Coprimary outcomes were incidence of airway stenting and acute cellular rejection (ACR) at 1 year.

Results

The trial was stopped after enrolling

SUBMITTER: Kraft BD 

PROVIDER: S-EPMC8026673 | biostudies-literature | 2021 Apr

REPOSITORIES: biostudies-literature